CANCER OF THE PROSTATE
Clinical trials for CANCER OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PROSTATE trials appear
Sign up with your email to follow new studies for CANCER OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in delaying prostate cancer spread
Disease control CompletedThis study tested a drug called enzalutamide in 1401 men with a type of prostate cancer that has stopped responding to hormone therapy but has not yet spread. The goal was to see if enzalutamide could delay the cancer from spreading to other parts of the body. Participants took e…
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
Radioactive therapy shows promise for tough prostate cancer
Disease control CompletedThis study tested a radioactive drug (I-131-1095) that targets prostate cancer cells. It included 120 men whose cancer had stopped responding to the drug abiraterone. Some men received the radioactive drug plus enzalutamide, while others got enzalutamide alone. The main goal was …
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Real-world study tracks how long men stay on prostate cancer treatments
Knowledge-focused CompletedThis study reviewed medical records from cancer clinics to see how long men with metastatic prostate cancer that still responds to hormone therapy take two common drugs, apalutamide and enzalutamide. It included about 1,300 men aged 18 and older who started one of these drugs as …
Matched conditions: CANCER OF THE PROSTATE
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC